|
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) |
|
ACAD's vs. Competition, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
| Acadia Pharmaceuticals Inc |
ACAD |
3,617 |
996 |
229 |
598 |
| Inhibikase Therapeutics Inc |
IKT |
180 |
0 |
-37 |
12 |
| Aptinyx Inc |
APTX |
7 |
2 |
-66 |
24 |
| Synaptogenix Inc |
SNPX |
3 |
0 |
14 |
10 |
| Amylyx Pharmaceuticals Inc |
AMLX |
441 |
196 |
-219 |
113 |
| Denali Therapeutics Inc |
DNLI |
2,178 |
111 |
0 |
445 |
| Aeon Biopharma inc |
AEON |
2 |
0 |
64 |
10 |
| Zyversa Therapeutics Inc |
ZVSA |
1 |
0 |
-9 |
0 |
| Tvardi Therapeutics inc |
TVRD |
43 |
0 |
0 |
0 |
| Conduit Pharmaceuticals Inc |
CDT |
3 |
0 |
-18 |
0 |
| Anavex Life Sciences Corp |
AVXL |
641 |
4 |
-47 |
20 |
| Vigil Neuroscience Inc |
VIGL |
321 |
0 |
-84 |
16 |
| Jazz Pharmaceuticals Plc |
JAZZ |
6,590 |
4,065 |
482 |
2,800 |
| Neurocrine Biosciences Inc |
NBIX |
12,610 |
2,413 |
306 |
1,400 |
| Sage Therapeutics Inc |
SAGE |
400 |
47 |
-354 |
353 |
| Zymeworks Inc |
ZYME |
860 |
93 |
-114 |
955 |
| Evoke Pharma Inc |
EVOK |
9 |
12 |
-5 |
8 |
| Neumora Therapeutics Inc |
NMRA |
116 |
0 |
-258 |
110 |
| Athira Pharma Inc |
ATHA |
12 |
0 |
-73 |
101 |
| Tg Therapeutics Inc |
TGTX |
5,715 |
386 |
39 |
132 |
| Alkermes Plc |
ALKS |
5,165 |
1,514 |
353 |
2,100 |
| Sagimet Biosciences inc |
SGMT |
114 |
0 |
-57 |
111 |
| Alterity Therapeutics Limited |
ATHE |
0 |
0 |
0 |
48 |
| Fortress Biotech Inc |
FBIO |
50 |
58 |
-107 |
101 |
| Biodexa Pharmaceuticals Plc |
BDRX |
0 |
0 |
-7 |
37 |
| Climb Bio Inc |
CLYM |
57 |
0 |
-74 |
0 |
| Metavia Inc |
MTVA |
7 |
0 |
0 |
0 |
| Zevra Therapeutics Inc |
ZVRA |
463 |
41 |
-92 |
23 |
| Avadel Pharmaceuticals Plc |
AVDL |
880 |
194 |
-26 |
154 |
| Cassava Sciences Inc |
SAVA |
97 |
0 |
-73 |
29 |
| Praxis Precision Medicines Inc |
PRAX |
812 |
9 |
-213 |
82 |
| Talphera Inc |
TLPH |
13 |
2 |
-13 |
0 |
| Horizon Therapeutics Public Limited Company |
HZNP |
27,190 |
3,643 |
438 |
1,300 |
| Takeda Pharmaceutical Company Limited |
TAK |
23,753 |
29,167 |
986 |
50,000 |
| Cormedix Inc |
CRMD |
726 |
0 |
-18 |
25 |
| Milestone Pharmaceuticals inc |
MIST |
100 |
0 |
-42 |
33 |
| Deciphera Pharmaceuticals Inc |
DCPH |
2,236 |
175 |
-190 |
355 |
| Assertio Holdings inc |
ASRT |
64 |
119 |
-31 |
300 |
| Vanda Pharmaceuticals Inc |
VNDA |
254 |
201 |
-44 |
500 |
| Intercept Pharmaceuticals inc |
ICPT |
794 |
288 |
-62 |
375 |
| Akebia Therapeutics Inc |
AKBA |
732 |
185 |
-45 |
410 |
| Supernus Pharmaceuticals inc |
SUPN |
1,771 |
668 |
62 |
652 |
| Nurix Therapeutics Inc |
NRIX |
888 |
56 |
-208 |
117 |
| Axsome Therapeutics Inc |
AXSM |
5,139 |
449 |
-284 |
48 |
| Gossamer Bio Inc |
GOSS |
252 |
125 |
-51 |
74 |
| Madrigal Pharmaceuticals Inc |
MDGL |
6,081 |
317 |
-392 |
53 |
| 89bio Inc |
ETNB |
1,440 |
0 |
-387 |
19 |
| Karuna Therapeutics Inc |
KRTX |
12,431 |
11 |
-396 |
10 |
| Iveric Bio Inc |
ISEE |
5,477 |
0 |
-223 |
105 |
| Bioxcel Therapeutics Inc |
BTAI |
6 |
2 |
-40 |
116 |
| Kinnate Biopharma Inc |
KNTE |
125 |
0 |
-127 |
99 |
| Terns Pharmaceuticals Inc |
TERN |
284 |
0 |
-90 |
59 |
| Ac Immune Sa |
ACIU |
145 |
15 |
-54 |
83 |
| Actinium Pharmaceuticals Inc |
ATNM |
46 |
1 |
-38 |
37 |
| Oramed Pharmaceuticals Inc |
ORMP |
93 |
3 |
-19 |
16 |
| Reata Pharmaceuticals Inc |
RETA |
7,154 |
3 |
-88 |
350 |
| Biomarin Pharmaceutical Inc |
BMRN |
11,409 |
2,950 |
524 |
3,401 |
| Adhera Therapeutics Inc |
ATRX |
0 |
2,732 |
-3 |
30 |
| Mira Pharmaceuticals Inc |
MIRA |
21 |
0 |
-8 |
0 |
| Inhibitor Therapeutics Inc |
HPPI |
14 |
0 |
-3 |
5 |
| Comera Life Sciences Holdings Inc |
CMRA |
0 |
1 |
-12 |
28 |
| Bioxytran Inc |
BIXT |
20 |
0 |
-3 |
0 |
| Tyme Technologies Inc. |
TYME |
54 |
0 |
-24 |
14 |
| Timber Pharmaceuticals Inc |
TMBR |
1 |
1 |
-15 |
10 |
| Inmed Pharmaceuticals Inc |
INM |
0 |
7 |
-3 |
11 |
| Clene Inc |
CLNN |
28 |
0 |
-29 |
76 |
| Effector Therapeutics Inc |
EFTR |
0 |
0 |
-35 |
47 |
| Qualigen Therapeutics Inc |
QLGN |
0 |
5 |
-9 |
49 |
| Affimed N v |
AFMD |
0 |
9 |
-119 |
102 |
| Acer Therapeutics Inc |
ACER |
16 |
0 |
-48 |
40 |
| Salarius Pharmaceuticals inc |
SLRX |
1 |
5 |
-6 |
8 |
| Paxmedica Inc |
PXMD |
0 |
0 |
-18 |
10 |
| Cohbar Inc |
CWBR |
1 |
0 |
-13 |
0 |
| Phio Pharmaceuticals Corp |
PHIO |
9 |
0 |
-7 |
10 |
| Unicycive Therapeutics Inc |
UNCY |
73 |
0 |
-15 |
11 |
| Bolt Biotherapeutics Inc |
BOLT |
12 |
4 |
-63 |
21 |
| Nextcure Inc |
NXTC |
14 |
0 |
-50 |
43 |
| Ngm Biopharmaceuticals Inc |
NGM |
127 |
4 |
-142 |
100 |
| Ibio inc |
IBIO |
8 |
2 |
-22 |
14 |
| Whitehawk Therapeutics Inc |
WHWK |
67 |
0 |
0 |
0 |
| I mab |
IMAB |
245 |
4 |
-22 |
0 |
| Spruce Biosciences Inc |
SPRB |
3 |
5 |
-55 |
22 |
| Kineta Inc |
KANT |
3 |
0 |
-8 |
50 |
| Lumos Pharma Inc |
LUMO |
36 |
2 |
-35 |
23 |
| Opus Genetics Inc |
IRD |
34 |
0 |
0 |
0 |
| Gain Therapeutics inc |
GANX |
41 |
0 |
-20 |
18 |
| Alimera Sciences Inc |
ALIM |
301 |
98 |
-15 |
159 |
| Tempest Therapeutics Inc |
TPST |
20 |
0 |
-45 |
18 |
| Oncternal Therapeutics Inc |
ONCT |
2 |
2 |
-35 |
24 |
| Y mabs Therapeutics inc |
YMAB |
207 |
89 |
-28 |
100 |
| Theravance Biopharma inc |
TBPH |
455 |
65 |
-58 |
202 |
| Enliven Therapeutics Inc |
ELVN |
889 |
0 |
-95 |
20 |
| Pliant Therapeutics Inc |
PLRX |
83 |
10 |
-220 |
26 |
| Xoma Royalty Corporation |
XOMA |
440 |
43 |
-10 |
13 |
| Longboard Pharmaceuticals Inc |
LBPH |
2,336 |
0 |
-76 |
37 |
| Crinetics Pharmaceuticals Inc |
CRNX |
2,841 |
5 |
-328 |
68 |
| Rhythm Pharmaceuticals inc |
RYTM |
3,867 |
137 |
-174 |
111 |
| Xenon Pharmaceuticals Inc |
XENE |
2,270 |
13 |
-251 |
142 |
| Nuvalent Inc |
NUVL |
5,343 |
4 |
-301 |
142 |
| Adc Therapeutics Sa |
ADCT |
301 |
71 |
-158 |
174 |
| Adagene Inc |
ADAG |
109 |
0 |
-33 |
77 |
| Adlai Nortye Ltd |
ANL |
79 |
5 |
-105 |
50 |
| Q Biomed inc |
QBIO |
0 |
0 |
-1 |
11 |
|
SUBTOTAL |
170,366 |
51,846 |
-3,999 |
70,445 |
|
